Search

everythinglearnresearchcommunity

for

Search:↓

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The risks of testosterone implants in women outweigh the benefits.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Hair transplantation can help transgender patients affirm their gender identity.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Testosterone is important for women's health, but more research is needed to guide its use.

Feminizing hormone therapy increases kidney filtration rate.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.